Healthcare provider profile · identity verified

Ravinderpal S Mann, M.D.

Internal Medicine · RANCHO MIRAGE, CA · NPI 1568480721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	293	74
Pantoprazole Sodium	Pantoprazole Sodium	272	101
Levothyroxine Sodium	Levothyroxine Sodium	231	57
Losartan Potassium	Losartan Potassium	228	60
Atorvastatin Calcium	Atorvastatin Calcium	209	62
Amlodipine Besylate	Amlodipine Besylate	182	48
Metoprolol Succinate	Metoprolol Succinate	175	49
Furosemide	Furosemide	151	47
Tamsulosin Hcl	Tamsulosin Hcl	141	40
Levofloxacin	Levofloxacin	137	97
Lisinopril	Lisinopril	134	35
Eliquis	Apixaban	120	29
Duloxetine Hcl	Duloxetine Hcl	119	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	118	32
Potassium Chloride	Potassium Chloride	111	39
Clopidogrel	Clopidogrel Bisulfate	95	26
Metformin Hcl	Metformin Hcl	89	21
Pregabalin	Pregabalin	85	17
Simvastatin	Simvastatin	81	21
Rosuvastatin Calcium	Rosuvastatin Calcium	75	27
Prednisone	Prednisone	71	27
Escitalopram Oxalate	Escitalopram Oxalate	64	17
Carvedilol	Carvedilol	63	18
Memantine Hcl	Memantine Hcl	60	14
Donepezil Hcl	Donepezil Hcl	56	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Famotidine	Famotidine	54	18
Clonazepam	Clonazepam	50	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	47	31
Levetiracetam	Levetiracetam	46	13
Lactulose	Lactulose	44	14
Omeprazole	Omeprazole	44	15
Calcitriol	Calcitriol	42	11
Tramadol Hcl	Tramadol Hcl	40	13
Albuterol Sulfate Hfa	Albuterol Sulfate	39	15
Finasteride	Finasteride	39	13
Allopurinol	Allopurinol	38	suppressed
Alprazolam	Alprazolam	38	suppressed
Spironolactone	Spironolactone	38	14
Temazepam	Temazepam	38	suppressed
Baclofen	Baclofen	37	suppressed
Clonidine Hcl	Clonidine Hcl	37	13
Synthroid	Levothyroxine Sodium	35	12
Acyclovir	Acyclovir	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Scopolamine	Scopolamine	34	suppressed
Humulin R	Insulin Regular, Human	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Jardiance	Empagliflozin	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	13
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Enoxaparin Sodium	Enoxaparin Sodium	29	suppressed
Glipizide	Glipizide	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Fluconazole	Fluconazole	26	13
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Atenolol	Atenolol	25	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Topiramate	Topiramate	22	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	11
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Valsartan	Valsartan	20	suppressed
Azithromycin	Azithromycin	18	14
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Clonidine	Clonidine	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Glimepiride	Glimepiride	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Methimazole	Methimazole	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Folic Acid	Folic Acid	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Estradiol	Estradiol	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Acarbose	Acarbose	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Torsemide	Torsemide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error